Literature DB >> 4404279

The use of prindolol (Visken) in the treatment of hypertension.

T O Morgan, W J Louis, J K Dawborn, A E Doyle.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4404279     DOI: 10.5694/j.1326-5377.1972.tb47306.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


× No keyword cloud information.
  18 in total

1.  A review of beta-blockers and their use in general practice.

Authors:  J C Davies
Journal:  J R Coll Gen Pract       Date:  1976-03

2.  Some aspects of the pharmacology of beta-adrenorecptor blockers.

Authors:  B Ablad; E Carlsson; C Dahlŏf; L Ek
Journal:  Drugs       Date:  1976       Impact factor: 9.546

Review 3.  Side effects and contraindications of beta-receptor blocking agents.

Authors:  H Lydtin
Journal:  Klin Wochenschr       Date:  1977-05-01

Review 4.  Hypertension: which beta-blocker?

Authors:  H J Waal-Manning
Journal:  Drugs       Date:  1976-12       Impact factor: 9.546

Review 5.  The second Lilly Prize Lecture, University of Newcastle, July 1977. beta-Adrenergic receptor blockade in hypertension, past, present and future.

Authors:  B N Prichard
Journal:  Br J Clin Pharmacol       Date:  1978-05       Impact factor: 4.335

6.  Sleep disturbances, nightmares and other possible central nervous disturbances in a population sample of women, with special reference to those on antihypertensive drugs.

Authors:  C Bengtsson; J Lennartsson; O Lindquist; H Noppa; J Sigurdsson
Journal:  Eur J Clin Pharmacol       Date:  1980       Impact factor: 2.953

7.  A double-blind crossover comparison of pindolol, metoprolol, atenolol and labetalol in mild to moderate hypertension.

Authors:  J J McNeil; W J Louis
Journal:  Br J Clin Pharmacol       Date:  1979       Impact factor: 4.335

8.  Effects of age and smoking on the pharmacokinetics of pindolol and propranolol.

Authors:  G Hitzenberger; P Fitscha; T Beveridge; E Nüesch; W Pacha
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

9.  Beta-adrenergic receptor blocking drugs, hypertension and plasma renin.

Authors:  T O Morgan; R Roberts; S L Carney; W J Louis; A E Doyle
Journal:  Br J Clin Pharmacol       Date:  1975-04       Impact factor: 4.335

10.  Hypotensive effect of oxprenolol in mild to moderate hypertension: a multicentre controlled study.

Authors:  M Motolese; G Muiesan; A Colombi
Journal:  Eur J Clin Pharmacol       Date:  1975       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.